Meet our Simoa® Accelerator Laboratory Leadership Team

Rely on our exceptional team of Simoa technology experts to ensure that your project receives the individualized attention required to help your organization achieve its research and development goals efficiently and cost-effectively.

Mary Ellen Cortizas, JD

mcortizas@quanterix.com

Vice President, CRO and Laboratory Services

Mary Ellen developed her operational expertise over a 30-year career at Boston Children’s Hospital. As Administrative Director of the Department of Laboratory Medicine, Mary Ellen had operational responsibility for clinical chemistry, hematology, microbiology, blood bank and molecular diagnostics. In addition to laboratory roles, Mary Ellen had active roles in enterprise-wide information technology, quality and regulatory management, emergency management, and strategic planning.

Prior to joining Quanterix, Mary Ellen was a founder and Chief Operating Officer at Claritas Genomics, a molecular genomics company dedicated to advancing precision care for pediatric rare disease. Claritas became the first clinical molecular diagnostic laboratory to achieve both ISO 15189 and New York State licensure for its unique exome-based diagnostics. Mary Ellen oversaw successful execution of a $9 million grant to sequence 20,000 exomes for the Veteran Adminstration’s Million Veterans project.

Mary Ellen has served on American Society of Clinical Pathologist Board of Registry exam committees, and is currently on the boards of two not-for-profit organizations focused on youth development.

Mary Ellen graduated from Suffolk Law School and holds a BA in Biology from Tufts University.

Linan Song, PhD

lsong@quanterix.com

Director, Accelerator Services

Dr. Song joined Quanterix in 2007, and is the director of the Accelerator Laboratory, a service business dedicated to clinical sample testing and the development of novel assays utilizing the company’s single molecule array (Simoa) technology. With over 10 years’ experience using Simoa, she leads the novel assay development working directly with clients and provides scientific support and guidance on clinical sample testing projects. Prior to Quanterix, Dr. Song worked at PerkinElmer Life Science, where she focused on mass spectrometer-based multiplexed protein assays used in studies of proteomics for novel biomarker discovery. Dr. Song obtained her Ph.D in Analytical Chemistry from the Department of Chemistry at Tufts University.

Lynn Brunelle, PhD

lbrunelle@quanterix.com

Director, Laboratory Operations

Dr. Lynn Brunelle joined Quanterix in May of 2020 and comes to us most recently from ALPCO, an immunoassay products company, where she oversaw the GMP manufacturing, QC and technical support areas for the last three and a half years. Prior to that, she was the Laboratory Director for Mayo Clinic’s reference laboratory based in Andover, MA for 15 years. Lynn has an undergraduate degree in Biochemistry and Molecular Biology and a PhD in Biomedical Sciences specializing in bleeding disorders. She is board certified by the American Association of Clinical Chemistry and is the CLIA Laboratory Director for Quanterix.

Scott Van Arsdell, PhD

svanarsdell@quanterix.com

Senior Director, Laboratory Services

Scott Van Arsdell, Senior Director, is currently managing the planar assay testing group in the Accelerator Services laboratory at Quanterix. Scott has previously held research and development management positions at Aushon BioSystems and Thermo Fisher Scientific. Scott holds a Ph.D. in Molecular Biophysics and Biochemistry from Yale University and completed postdoctoral training at the University of California, Berkeley.

Mingwei Zhao, PhD

mzhao@quanterix.com

Principal Scientist, Accelerator Services

Mingwei joined Quanterix in 2012 and currently leads a team of research associates and scientists to develop, optimize, and troubleshoot customized biomarker assays and utilizes the Simoa platform to fulfill services for our customers. Prior to joining Quanterix, Mingwei was a Research Fellow at Harvard University, where he was leading the research of signaling pathways and regulation of innate immune response to infectious disease. Mingwei holds a Ph.D. in Biochemistry from the Chinese Academy of Science and completed a postdoctoral fellowship in Molecular and Cellular Biology at Harvard University.

Ready to take your biomarker research to the next level?

request a quote